The intracellular signaling cascades through which corticosterone rapidly alters neuronal activity are poorly defined. Results: Corticosterone alters glutamatergic transmission by activating diverse GPCRdependent signaling pathways. Conclusion: Corticosterone-induced changes in neuronal excitability are initiated at the plasma membrane. Significance: The sequential recruitment and integration of diverse signaling cascades by corticosterone adds to the understanding of how steroids rapidly alter neuronal function.
and nuclear functions, introduces a potential mechanism through which rapid signaling initiated at the plasma membrane may eventually determine the long-term integrated response to corticosterone by impacting on the transcriptional machinery that is regulated by classical, nuclear mineralocorticoid and glucocorticoid receptors.
Glucocorticoids (GC e ) are essential for immediate and long-term behavioral and physiological adaptations to stress. Generally, the adaptations triggered by GC secretion are considered to result from activation of glucocorticoid (GR) and/or mineralocorticoid (MR) receptors, ligandactivated transcription factors (or nuclear receptors) that regulate gene expression. On the other hand, GC can induce rapid changes in neural activity: alterations in neuronal activity (1, 2) , cell signaling (3), glutamate release (4), NMDARmediated Ca 2+ currents (5), behavior (6-9) and neuroendocrine regulation (10) are observable within seconds-to-minutes of treating animals or ex vivo brain slice preparations with the major GC in rodents corticosterone (CORT) (11) . In addition, GC rapidly increase hippocampal neuron spine density (12) and modulate network dynamics (13) . Moreover, functional neuroimaging in rats has revealed that CORT rapidly modulates the coordinated activity of the forebrainhippocampal-hypothalamic circuitry and thus probably facilitates early cognitive and behavioral responding to exogenous stimuli (14) .
A common finding in previous studies was that gene transcription and protein translation are not required for the rapid actions of CORT on neuronal function (11, 12, 15) . Notwithstanding some exceptions (1, 8) , the fast neuronal actions of CORT do not appear to be mediated by nuclear MR and GR. The present study used an approach that was not constrained by a priori assumptions about the nature of the receptor that mediates the rapid effects of CORT. Specifically, we screened for the involvement of non-receptor tyrosine kinases (NRTK), a strategy chosen in light of the widespread involvement of these kinases in signaling modules from several types of receptors and their ability to serve as a convergence point for multiple pathways (16) (17) (18) (19) . Our investigations reveal that CORT recruits a series of diverging and converging signaling pathways that ultimately influence postsynaptic structure and function. Briefly, we show that fast CORT signaling relies on a core of TK including Pyk2, Abl and Src that are activated by converging PKC, PKA and Akt/PKB pathways, downstream of a putative G protein-coupled receptor (GPCR) coupled to Gi/o proteins. These results offer new mechanistic insights into fast CORT-induced signaling in hippocampal neurons and provide a framework to better understand how membraneproximal mediators integrate diverse signals and link with nuclear receptors to elicit molecular and cellular responses to facilitate physiological and behavioral adaptation.
EXPERIMENTAL PROCEDURES
Primary neuronal cultures -Trypsin-dissociated primary hippocampal cell cultures were prepared from 4-day-old rats, as described previously (20) . Cells were grown at a density of 450-500 cells/mm 2 . Experiments were started after 10-13 days in vitro (DIV 10-13).
Pharmacological agents -The following drugs were obtained from Sigma (Deisenhofen, Germany) and used at the final concentrations indicated in square brackets: AG1478 (selective inhibitor of EGFR kinase) [ [1 µM] , and the inhibitor of spleen tyrosine kinase (Syk) [ 1 µM] were obtained from Calbiochem (La Jolla, CA). Cellimpermeable CORT-BSA (corticosterone-3-Ocarboxymethyloxime-BSA; used at 100 nM) was purchased from ABiox (Newberg, OR), pertussis toxin (PTX; G i -and G o -protein inhibitor) [500 mg/L] from List Biologicals (Campbell, CA), PF431396 (potent pyrimidine-based Pyk2 inhibitor) [3 µM ] from Symansis (Timaru, New Zealand), and STI-571 (imatinib, selective inhibitor of c-Abl) [ 1 µM] from Cayman (Ann Arbor, MI). The selective GR antagonist J2700 (a gift from Jenapharm, Jena, Germany) was used at 100 nM.
Immunocytochemistry and image analysisImmunolocalization studies were performed on paraformaldehyde-fixed neurons that were incubated (4°C, 18 h) with antibodies against MAP2a/b (Sigma; 1:500), NR2B subunit (Sigma; 1:200), PSD-95 (Acris, Herford, Germany; 1.400), Pyk2 (pTyr402, Invitrogen, Darmstadt, Germany; 1:200) and Synapsin 1 (Sigma; 1:750). Surface NR1 expression was performed by quickly cooling cells to 4°C and incubation with anti-NMDAR1 (BD Biosciences, San Jose, by guest on November 7, 2016 http://www.jbc.org/ Downloaded from CA 1:100 in Neurobasal medium, 15 min), before fixation, blocking and permeabilization (5% BSA and 0.001% Triton X-100) and incubation with anti-synapsin-I (1:750; 4°C, 18 h). Immunosignals were visualized after extensive washing and incubation (1 h, RT) with appropriate secondary antibodies (mouse, conjugated with Alexa-488, or rabbit conjugated with Alexa-594, both from Invitrogen). Images were acquired with an Olympus FluoView1000 confocal microscope using a plan-apochromat 63x/1.2 water lens, at a resolution of 1024 x 1024 in 8-bit format. Phospho-Pyk2, NMDAR1, NR2B, and PSD-95 cluster size were analyzed using ImageJ software after intensity-thresholding at the arbitrary value of 100, 80, 150, 180 and 180, respectively. Only clusters juxta-posed to synapsin puncta (manually selected by an investigator who was blind to the treatments) were evaluated; surface areas were measured with ImageJ software. Clusters separated by 1 pixel were considered to represent distinct clusters. Only clusters ≥ 3 pixels were included in the analysis (noise reduction); while this criterion possibly introduced a bias toward smaller differences in treated vs. untreated groups in cases where treatment caused a shrinkage of a substantial proportion of clusters to < 3 pixels, it would rather lead to an overestimation of average cluster size in the treated groups without undermining the statistical significance of detected differences. The cluster size analysis was complemented by independent evaluation of the images by a second investigator (also blind to treatments) who ranked images according to cluster size; in all cases, there was a 100% match between these latter qualitative evaluations and the quantitative analysis.
Immunoblotting -Neurons were lysed by brief sonication in complete RIPA buffer (with protease phosphatase inhibitor cocktails), before clearing by centrifugation (12,000 g, 10 min). Cleared lysates (40 µg) were fractionated by electrophoresis on 8% SDS-polyacrylamide (PAGE) gels and transferred onto nitrocellulose membranes, blocked (5% non-fat dried milk powder and 0.2% Tween-20 in PBS) and incubated with antibodies against c-Abl (1:1000), NMDAR-pTyr1472-NR2B (1:1000), pERK1/2 (p44/42, 1:1000), pTyr-100 (phospho-Tyrosine 100; 1:1000), Pyk2 (1:2000), Src pTyr416 (1:1000) and Src pTyr527 (1:1000) from Cell Signaling (Danvers, MA); Pyk2 pTyr402 (1:1000), Pyk2 pTyr579 (1:1000), Pyk2 pTyr580 (1:1000) and Pyk2 pTyr881 (1:1000; Invitrogen), c-Abl pTyr 412 (1:1000; Novus Littleton, CO) and actin (1:5000; Millipore, Billerica, MA). Anti-PTP-PEST pSer39 (1:1000) was a generous gift from Dr. K. Mashima (Rikkyo University, Japan). Antigens were detected by enhanced chemiluminescence (GE HealthCare, Freiburg, Germany) after incubation with appropriate horseradish peroxidase-IgG conjugates (GE HealthCare). Blots were scanned and quantified (TINA 3.0 Bioimaging software, Raytest, Straubenhardt, Germany) after subtraction of local background. The p-Tyrosine blots were not intended to provide high-resolution separation of single bands and were therefore analyzed by averaging the density of 10 large bands after subtracting the corresponding local background. Linearity was routinely checked before semiquantification of all blots. Normalized data are expressed as percentage of controls.
Statistics -Numerical data are depicted as mean ± SD (3-5 independent experiments). Immunofluorescence data derive from evaluation of a minimum of 600 synapses (N) in each of 8-10 neurons (n). Data were analyzed for statistical significance using ANOVA and appropriate post hoc tests (Student-Keuls or Kruskal-Wallis multiple comparison procedures, as appropriate) where p < 0.05 was set as the minimum level of significance.
RESULTS
Corticosterone activates the Src-family kinase signaling pathway -Tyrosine kinases (TK) are expressed in neurons and are particularly enriched in synapses (21-24) where they phosphorylate and activate a range of substrates (25). A first set of experiments investigated the overall activation of tyrosine kinases following exposure of hippocampal neurons to CORT. Analysis of dose-response curves (1-1000 nM CORT) showed that tyrosine phosphorylation was most effectively triggered by CORT at a dose of 10 nM (not shown). Immunoblot analysis of the global levels of p-Tyrosine revealed a large number of bands, with MW ranging from by guest on November 7, 2016 http://www.jbc.org/
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Critical role of Pyk2 in fast corticosteroid signaling 4 20 to 200 kDa. Levels of tyrosine phosphorylation were significantly increased within 5 min of application of CORT and peaked at 20 min (p < 0.05) (Fig. 1A) ; accordingly, all further analysis was confined to the first 20 min after treatment to focus on dissection of the early signaling events initiated by CORT. As shown in Fig. 1B , blockade of protein synthesis with cycloheximide did not interfere with the effect of CORT on tyrosine phosphorylation (p > 0.05), excluding the involvement of translational mechanisms.
Because post-mitotic primary neuronal cultures are not easily amenable to efficient transfection, pharmacological antagonism was used to identify the TK recruited by CORT signaling; specifically, we performed a screening with small molecule TK inhibitors that target the Srcfamily kinase (SFK), Abl, and inhibitors of the JAK-STAT and of spleen tyrosine kinase (Syk) pathways. In addition, the efficacy of CORT signaling was tested in the presence of inhibitors of two abundant receptor tyrosine kinases (RTK), namely, TrkB and epidermal growth factor receptor kinase (EGFR-kinase). The SFK inhibitor PP2 markedly attenuated the upregulation of p-Tyr by CORT (p < 0.05), whereas inhibitors of c-Abl (ST1571) and JAK produced weaker, albeit significant effects (Fig.  1C) ; inhibitors of TrkB (K252a) and EGFRkinase (AG1478) did not significantly influence the effects of CORT on pTyr levels (Fig. 1D) . Confirming the essential role of SFK, we observed that the Src-family inhibitor SU6656 inhibits CORT-induced TK phosphorylation (p < 0.05) in a fashion that is comparable to that seen with the structurally-unrelated compound PP2 (Fig. 1E) ; on the other hand, PP3, an inactive analog of PP2, did not exert any effect (Fig. 1E) .
Corroboration of the above evidence of SFK involvement in CORT-induced TK phosphorylation was obtained by analysis of the phosphorylation state of Src in whole-cell extracts from CORT-treated hippocampal neuronal cultures. To this end, antibodies directed against pSrc (Y416; located in the kinase domain responsible for activation of Src) and the autoinhibitory site pSrc (Y527) were employed. We observed that CORT significantly upregulated phosphorylation of Src at the Y416 site (p < 0.05) within 10 min of drug application, with peak levels of activation being seen after 30 min (Fig. 1F) . Conversely, a significant decrease (p < 0.05) in pSrc Y527 was observed within 30 min of CORT application (Fig. 1E) . Together, the above findings identify Src as a major mediator of a non-genomic signaling cascade initiated by CORT.
Pyk2 phosphorylation mediates CORTinduced Src activation -This set of experiments aimed at identifying CORT-triggered signaling events that occur upstream of the Src family (SFK) members. Numerous stimuli and mechanisms contribute to the activation of SFK (26); among these, the TK scaffold protein Pyk2 has emerged as a prominent and direct activator of Src in hippocampal neurons (21) . Here, pretreatment with PF431396, a specific Pyk2 inhibitor, abolished CORT-induced activation of SFK ( Fig.  2A) . Consistent with this finding, Pyk2 was activated by CORT, evidenced by increased phosphorylation of its Y402 residue; this effect was significant within 10 min of CORT application and progressively increased for at least 60 min thereafter (Fig. 2B) . CORT-induced phosphorylation of Pyk2 was further confirmed by immunostaining of hippocampal neurons with anti-pPyk2 Y402 and synapsin I (Syn-I, to identify synaptic sites). At baseline, pPyk2 Y402 was detectable at low levels in neuronal cell bodies and nuclei, with very low levels of pPyk2 being detectable along major dendrites; only rarely were pPyk2 puncta found adjacent to Syn-I puncta. However, pPyk2 immunoreactivity (fluorescence intensity) was markedly increased (3-fold) 20 min after CORT application; pPyk2 appeared as puncta along dendrites and was largely co-localized with Syn-I, indicating selective Pyk2 phosphorylation at synaptic sites (Fig. 2C) .
Next, a detailed analysis of Pyk2 activation by CORT exposure was conducted by focusing on 4 critical phospho-epitopes: the autophosphorylation site Y402 (required for initial kinase activation), the kinase domain sites Y579 and Y580 (required for full kinase activity), and Y881 (located in the C-terminal interaction domain). All epitopes underwent significant phosphorylation when hippocampal neurons were treated with CORT for 20 min (p < 0.05; Fig.  2D ). Underlining the crucial role of the Pyk2 autophosphorylation site, we observed that blockade of phosphorylation of Y402 with the Pyk2 inhibitor PF431396 prevented CORTinduced phosphorylation of other Pyk2 phosphoepitopes (Y579, Y580 and Y881). The Src inhibitor PP2 did not interfere with phosphorylation of Y402 but effectively blocked phosphorylation of Pyk2 at Y579, indicating dependence on Src activation. Thus, upon activation by Pyk2, Src 'back phosphorylates' Pyk2, amplifying Pyk2 activity. Interestingly, inhibition of Src only partially reduced CORT-induced phosphorylation of Pyk2 at Y580 and Y881, suggesting involvement of other (non-SFK) kinases in the regulation of these sites.
Convergence of PLC-PKC-, PKA-and
Akt/PKB-dependent pathways required for CORT-induced Pyk2 activation -Pyk2 is a signaling hub with inputs from several pathways and second mes-sengers, in particular Ca 2+ -and PKC-dependent mechanisms (27). It was therefore of interest to explore the potential involvement of proximal transduction pathways, specifically PKC, PKA and Akt/PKB signaling cascades. A pharmacological screen revealed that CORT-induced phospho-rylation of the Y402 autophosphorylation site on Pyk2 is blocked in the presence of an inhibitor of PKC (Gö69), but not inhibitors of PKA (H89) or Akt/PKB (AP1-2) (cf. Fig. 3A and 3D) . Results indicate that the pathway upstream of PKC requirees PLC activation and calmodulin function since Pyk2 phosphorylation was prevented when neurons were treated with inhibitors of either PLC (U73122; Fig. 3A ) or calmodulin (W7; Fig. 3B ). The latter result, pointing to a Ca 2+ -dependent mechanism, was confirmed by the finding that the CORT effect was prevented when cells were co-treated with either the Ca 2+ chelator BAPTA-AM or the IP3 receptor antagonist 2-APB which blocks mobilization of intracellular Ca 2+ (Fig. 3C) . Notably, verapamil, an L-type voltage-dependent Ca 2+ channel (VDCC) blocker, did not affect CORT-induced Pyk2 phosphorylation (not shown), ruling out the requirement of Ca 2+ influx through this type of VDCC.
As mentioned above, efficient Pyk2 activation and substrate recruitment following its autophosphorylation at Y402 requires phosphorylation of three further tyrosine residues: Y579 and Y580 in the kinase domain and Y881 in the C-terminal interaction domain (27). Consistent with this, the present experiments revealed that while the autophosphorylation of Pyk2 is solely dependent on PKC signaling (Fig 3D) , its phosphorylation at the Y579 and Y580 residues requires PKA and Akt/PKB activity; specifically, phosphorylation at these sites was prevented when cells were treated with inhibitors of PKA (H89), PI-3K (wortmannin) and Akt/PKB (AP1-2) (Fig 3D) . Interestingly, phosphorylation of the Y881 epitope was sensitive to blockade with wortmannin and API-2, but not H89 (Fig 3D) . Thus, while activation of the PLC-PKC pathway is sufficient to induce autophosphorylation of Pyk2 (Y402), recruitment of additional signaling cascades is required to achieve phosphorylation of Pyk2 at its Y579, Y580, and Y881 residues.
The finding that PKA and Akt/PKB contribute to the regulation of specific phosphotyrosine residues in Pyk2 by CORT led us to hypothesize the involvement of an intermediate player such as the phosphatase PTP-PEST, a recently identi-fied negative regulator of Pyk2 (28,29). Pre-vious work showed that PTP-PEST is constitu-tively active and represses Pyk2 activation under basal conditions and that the phosphatase is inactivated upon phosphorylation at the serine 39 (S39) site (30,31). The present results show induction of phosphorylation of PTP-PEST at S39 within 5 min of exposure of hippocampal neurons to CORT, with peak levels of phosphorylation occurring after 20-30 min (Fig. 4A) . The finding that inhibitors of PKA (H89), Akt/PKB (API-2), PI-3K (wortmannin) and PKC (Gö69) block the CORT-induced upregulation of p-S39 PTP-PEST suggests involvement of all three path-ways in the inhibition of PTP-PEST activity and that the ability of PKA and Akt/PKB to regulate the phosphorylation of some Pky2 epitopes depends on PTP inhibition ( Fig. 4B and  C) .
Together, the above data suggest that activation of the PLC-PKC cascade is an absolute requirement in CORT-induced autophosphorylation of Pyk2 at Y402. At the same time, the data show that PKA and Akt/PKB mediate the inhibitory actions of CORT on PTP-PEST, thus CORT activates the Abl cascade through Pyk2 -Since the Abl inhibitor STI571 reduced CORT-induced pTyr levels (Fig. 1C) , and given that c-Abl can be recruited to Pyk2 at Y881 (32,33), it was of interest to investigate whether c-Abl, alongside Pyk2 and Src, was activated by CORT. The results in Fig. 5A show that CORT leads to robust and sustained autophosphorylation of c-Abl at its Y412 epitope within 20 min of application (p < 0.05). Moreover, inhibition of the upstream kinases SFK and Pyk2 ( 
Implication of a surface-localized GPCR -
The engagement of PLC-PKC and PKA pathways by CORT in activating Pyk2 hinted at the potential signaling role of G proteins. Consistent with previous demonstrations that the PLC-PKC pathway can be activated by PTX-insensitive Gq-alpha subunits as well as PTX-sensitive Gibeta/gamma subunits (34), we here observed that pretreatment with pertussis toxin (PTX) prevents CORT-triggered phosphorylation of Pyk2 and Src (Fig. 6A) ; these findings implicate the involvement of the beta-gamma subunits of Gi (34).
To test the possibility that fast CORT signaling originates at the plasma membrane, a cellimpermeable CORT-BSA conjugate was used to exclude binding to intracellular (nuclear) MR and GR. Exposure of hippocampal neurons to this conjugate produced the same degree of Pyk2 phosphorylation (at Y402) as CORT (Fig. 6B , lanes 1 and 2). Moreover, the actions of both, CORT and CORT-BSA were insensitive to other, structurally unrelated antagonists of nuclear GR (RU38486, J2700) and nuclear MR (RU28318, eplerenone and spironolactone) (Fig. 6B) . Importantly, pretreatment of hippocampal cultures with a general GPCR inhibitor (SCH 20267) abolished CORT activation of Pyk-2 ( Fig. 6C) . Investigation of further upstream events revealed that the actions of both CORT-BSA and unconjugated CORT were sensitive to PTX and Gö69, the PKC inhibitor (Fig. 6D ). These observations indicate that CORT-BSA and CORT initialize an identical signaling cascade and their pharmacological profile suggests that the fast actions of both compounds are mediated by a membrane-localized entity that uses a putative GPCR-mediated transduction pathway.
CORT induces phosphorylation of NMDAR through Pyk2 and Src -We next explored the synaptic consequences of fast CORT signaling through TK, focusing on the most abundant synaptic phospho-tyrosine proteins (25), namely the NR2A and NR2B subunits of NMDAR. Given the above-described effects of CORT on TK signaling, and the known role of TK in preventing NMDAR endocytosis through phosphorylation of the NR2B subunit at Y1472, (26,35,36) we examined the influence of CORT on the dynamic processes that regulate NMDAR expression at the neuronal surface. Expression of surface NR1, under non-permeabilizing conditions, was monitored using an antibody directed against an extracellular epitope. As shown in Fig. 7A , CORT treatment up-regulated NR1 immunoreactivity at the cell surface, an effect that was sensitive to inhibition of Pyk2 and SKF; interestingly, inhibition of Abl did not interfere with the actions of CORT on NR1 expression. These data were confirmed by monitoring phosphorylation of the Y1472 on NR2B cytoplasmic tail (35,36) by immunoblotting of whole cell extracts (Fig.  7C) . Together, these observations indicate that Pyk2 and Src contribute to the regulation of the surface expression of NMDAR by CORT.
Scaffold proteins play an important modulatory role in NMDAR surface localization and sig-naling (37,38). Accordingly, we monitored the pattern of clustering of PSD-95, a scaffold pro-tein found in the neuronal post-synaptic density (20) after treating hippocampal neurons with CORT (10 nM) for 30 min. Immunostaining for PSD-95 and synapsin (to mark synapses) revealed that, whereas PSD-95 in dendritic spines is largely punctate and occurs in close apposition to synapsin-positive puncta under baseline conditions, PSD-95 cluster size increases within 20 min of CORT application. Importantly, the latter effect is blocked in the presence of inhibitors of Pyk2, Src as well as Abl (Fig 7B) . Thus, al-though NR2B phosphorylation does not require Abl (cf. Fig.  7A ), the signaling pathway that regulates PSD-95 clustering is critically dependent on Abl.
A functional correlate of the observed CORTinduced increase in surface-localized NMDAR was obtained by examining phosphorylation of the MAP kinase ERK1/2. Consistent with previous work showing that NMDAR activation results in the phosphorylation of ERK1/2 (p44/p42) (39), we here observed a significant increase in pERK1/2 levels within 20 min of CORT application to hippocampal neurons (Fig.  7D) ; abrogation of this effect by MK801, a noncompetitive NMDAR antagonist (Fig. 7E) , demonstrated dependence on glutamatergic transmission. As depicted in Fig. 7F , an inverted U-shaped dose-response curve was obtained when levels of pERK1/2 were measured in neurons that were exposed to CORT; a similar dose-response curve was observed when neurons were treated with membrane-impermeable CORT-BSA conjugate (not shown).
Together, these sets of data show that tyrosine phosphorylation of NR2B leads to increased surface expression of NMDAR and PSD-95 clustering; in turn, these events activate the ERK1/2 pathway.
DISCUSSION
Glucocorticoids induce rapid changes in the function of both neuronal and non-neuronal cells through signaling mechanisms that are believed to originate at the plasma membrane which are, however, poorly understood. In this study, we undertook a comprehensive analysis of both, membrane-proximal and -distal signaling pathways that are activated within 20 min of CORT application to cultured hippocampal neurons.
Our results reveal that fast CORT signaling in hippocampal neurons occurs in three, sequentially interconnected steps: events at the plasma membrane that activate serine-threonine kinases, activation of core non-receptor TKs, and finally, alterations in synaptic activity. None of these effects can be blocked in the presence of antagonists of nuclear GR and MR. On the other hand, results showing that both, unconjugated CORT and membrane-impermeable CORT-BSA (also see 2, 3) elicit identical signaling events, strongly suggest that a membrane-bound receptor for CORT is responsible for mediating the rapid neuronal actions of this steroid. While the latter were found to be sensitive to Gi/o inhibition (PTX) and to a general inhibitor of GPCR function (SCH 20267), the nature of the putative membrane-localized CORT receptor remains unknown. While some earlier studies observed immunoreactivity corresponding to the classical, nuclear GR in the plasma membrane (12, (40) (41) (42) , more recent ones have proposed that the fast actions of CORT in hippocampal neurons are medi-ated by translocated nuclear MR (7, 43) . It is pertinent to note that recent work has implicated an orphan GPCR in fast signaling by two other steroid hormones, estradiol and aldosterone (44,45); the latter is enzymatically (18-hydroxylase and 18-hydroxysteroid dehydrogenase) derived from CORT.
Downstream of the Gi/o-mediated events, our data show that CORT activates diverging signaling cascades. Expanding the scope of previous reports on CORT activation of PKA and PKC, with subsequent alterations of NMDA receptor trafficking and integration into the postsynaptic density (3,5), our study shows that recruitment of downstream signaling molecules depends on the simultaneous activation of PKC, Akt/PKB, and PKA. Given that the synaptic actions of many neurotransmitters and neuromodulators occur through activation of PKA, Akt/PKB, and PKC (for example see 46), activation of these divergent pathways during the initial phases of the rapid response to CORT provides the cell with a high degree of plasticity, including crosstalk and cross-modulation. Involvement of other signal-ing cascades is conceivable if the membrane ac-tions of CORT are indeed mediated by a GPCR that results in the assembly of a signalosome. Here, CORT was found to upregulate pERK in an NMDAR-dependent manner, but CORT-induced changes in JNK and p38 activation were not observed. This suggests that activation of the PKA, Akt/PKB and PKC pathways may be the most prominent proximal events in rapid CORT sig-naling initiated at the plasma membrane.
Our experiments show that the PKA, Akt/PKB and PKC pathways eventually converge on Pyk2, a scaffold tyrosine kinase by guest on November 7, 2016 http://www.jbc.org/
Downloaded from
Critical role of Pyk2 in fast corticosteroid signaling 8 known to be a key player in GPCR-mediated signaling in neu-rons (46), in agreement with previous studies (21, 47 ,48 and as shown in Fig  8) . Two mech-anisms regulate the activation of Pyk2: the first, direct, one which leads to its initial autophos-phorylation, is Ca 2+ -dependent; the second in-volves dephosphorylation by various phospha-tases (49), the tyrosine phosphatase PTP-PEST being a prime example. Regulation of Pyk2 by PTP-PEST has been described in a number of non-neuronal cellular contexts (50,51), and PTP-PEST has been shown to control dendritic arborization (52) by dephosphorylating Pyk2 and other proteins of the focal adhesion com-plex. PTP-PEST affect the phosphorylation status of a large set of proteins (53) and therefore it is conceivable that PTP-PEST contributes an addi-tional, and currently un-known, layer of complexity to fast CORT-triggered signaling pathways.
The activation of Pyk2, a core non-receptor TK represents a major point for integrating upstream signals and, at the same time, a hub from which divergent downstream cascades can emerge. While the extent of Pyk2 activation is controlled at several check-points (PKCdependent autophosphorylation and Akt/PKBand PKA-dependent relief of the inhibitory effect of PTP-PEST), Pyk2 autophosphorylation and the subsequent activation of Src or Fyn, which back-phosphorylate Pyk2, form a positive feedback loop that ensures signal amplification. However, since direct competitive binding of Pyk2 to the SH2 domain of Src (or Fyn) dispenses with the need for full dephosphorylation of its Y527 in-hibitory site (54), it is interesting that phos-phorylation of Src Y527 is detectable even when the Y416 site is strongly phosphorylated (Fig. 1E) . Our results show CORT to be an efficient activator of Pyk2; for example, we observed a 3-fold increase in local pPyk2 levels (Fig. 2B) .
Pyk2 as well as Src and Fyn reside in close contact with post-synaptic density (PSD) proteins (23) , and Pyk2 is involved in several types of synaptic plasticity (21, 55) . The ability of CORT to rapidly activate Pyk2 suggests that this hormone has the potential to modulate a large number of synapses within a very short timeframe. Moreover, since Pyk2 is also implicated in the extra-synaptic regulation of the dendritic cytoskeleton (56), it is likely that CORT can also rapidly influence dendritic architecture. The Cterminus of Pyk2 is known to serve as scaffold module on whose phosphotyrosines multiple adaptors (e.g. vav and Grb2, 57), signaling molecules (e.g. RasGAP and RhoGAP, 58, 59), and various other kinases, can be recruited and/or phosphorylated to provide further signaling divergence (Fig. 8) .
The present work identifies Abl as a target of fast CORT signaling initiated at the plasma membrane of hippocampal neurons (Fig. 5) . Our results indicate that CORT-induced activation of Abl occurs downstream of Pyk2 and independently of NMDAR, and that its activation lags behind that of Pyk2 and Src. Moreover, by using a highly specific Abl kinase inhibitor (STI571), we show that Abl signaling increases clustering of PSD-95, consistent with the results of another recent study (24). Since PSD95 clustering leads to increased autophosphorylation of Pyk2 (23), CORT-induced activation of Abl and PSD-95 clustering provides additional amplification of Pyk2 signaling (beyond and downstream of the Pyk2/Src interaction). Interestingly, by phosphorylating WASP and WAVE complexes Abl serves as a powerful regulator of the actin cytoskeleton (33); given the crucial role of actin in spine physiology (60), we suggest that the Pyk2-Src-Abl module may explain the previously reported fast actions of CORT on spine morphology (12) .
Analysis of morphological correlates of synaptic plasticity revealed that CORT rapidly alters NMDAR localization and PSD-95 clustering. Since plasticity-inducing stimuli are known to regulate cell surface availability of NMDAR through Pyk2 and its SFK-dependent amplification loop (21,61,62), we here monitored synaptic NMDAR surface localization in CORTtreated hippocampal neurons. Our results show concomitant increases in the phosphorylation of the Y1472 residue in the cytoplasmic tail of the NR2B subunit of the NMDAR and surface retention of NMDAR after CORT application, providing a molecular explanation for the induction of fast CORT-induced changes in NMDARinduced Ca 2+ currents (5) . Previous studies showed that the cytoplasmic tail of the NR2 subunit is a major target of TK, with the Y1472 residue appearing to be a major regulator of NMDAR endocytosis since it provides the binding site for the endocytic adaptor AP-2 (35,36).
The fast increase in surface NMDAR expression after CORT application was associated with an upregulation of other, NMDAR-dependent, down-stream signaling pathways such as ERK1/2 (and CaMKII and pCREB, not shown) that influence the transcriptional machinery. In this context, it should also be noted that, besides their roles in modulation of synaptic structure and activity, Pyk2 and Abl can modulate gene transcription after translocation to the nucleus, at least in non-neuronal cells (63) (64) (65) (66) . Thus, the potential of the NMDAR-and Pyk2-Abl-initiated cascades to converge with or "prime" the transcriptional response to activated nuclear GR adds an additional layer of complexity to the mechanisms through which CORT can alter neuronal activity. Interestingly, CORT rapidly modulated or triggered signaling cascades from unrelated receptors. The possibility of such "receptor transactivation" (see ref. 19 ) was investigated, but neither EGFR nor TrkB were found involved in CORT-initiated cascades (see Fig. 1 ); notably, a major contribution of CORTstimulated signaling cascades comes from the recruitment and activation of NMDAR, which leads to a significant induction of ERK phosphorylation. In fact, CORT-induced activation of the ERK pathway appears to be largely, if not only, due to NMDAR activity. Thus, overall rapid CORT signaling may involve extensive overlap and cross-modulation of signaling from other neurotransmitter receptors, with consequences that have yet to be elucidated.
The present results (see Fig. 8 ) provide a comprehensive analysis of the non-genomic signaling cascades triggered by CORT at the plasma membrane of hippocampal neurons. They demonstrate that divergent pathways downstream of a putative GPCR converge to feed into a major signaling hub (TK), and subsequently influence functional targets such as NMDAR and PSD-95. These mechanisms are likely to explain the rapid effects of CORT on synaptic function (11), behavioral and endocrine responses (6, 10) , and remodeling of neuronal networks (14) . Previously, convergence of CORT-triggered signaling pathways was only known in the context of transcriptional regulation (67); the present report showing the convergence of multiple upstream cascades on Pyk2 represents a new level of integration of CORT signaling with other pathways, including the nuclear GR pathway. 
